المؤلفون: Michaels E; Department of Medicine, The University of Chicago Medicine, Chicago, IL., Chen N; Department of Medicine, The University of Chicago Medicine, Chicago, IL; Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL., Nanda R; Department of Medicine, The University of Chicago Medicine, Chicago, IL; Department of Medicine, The University of Chicago Comprehensive Cancer Center, Chicago, IL. Electronic address: rnanda@medicine.bsd.uchicago.edu.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2024 Jun; Vol. 24 (4), pp. 263-270. Date of Electronic Publication: 2024 Mar 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/immunology , Triple Negative Breast Neoplasms*/pathology , Immunotherapy*/methods, Humans ; Female ; Biomarkers, Tumor/metabolism ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology

المؤلفون: Emens LA; Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA jlitton@mdanderson.org emensla@upmc.edu., Adams S; Perlmutter Cancer Center, New York University Langone, New York, New York, USA., Cimino-Mathews A; Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Disis ML; Cancer Vaccine Institute, University of Washington, Seattle, Washington, USA., Gatti-Mays ME; Pelotonia Institute for Immuno-Oncology, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Ho AY; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Kalinsky K; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., McArthur HL; Department of Medicine, UT Southwestern, Dallas, Texas, USA., Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Nanda R; Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, USA., Page DB; Earle A Chiles Research Institute, Portland, Oregon, USA., Rugo HS; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Rubin KM; Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Soliman H; Department of Breast Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Spears PA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Litton JK; Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA jlitton@mdanderson.org emensla@upmc.edu.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Aug; Vol. 9 (8).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy/*methods , Triple Negative Breast Neoplasms/*therapy, Female ; Guidelines as Topic ; Humans ; Societies, Medical ; United States ; United States Food and Drug Administration

المؤلفون: Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori 'Fondazione G. Pascale', Via Mariano Semmola, 80131, Naples, Italy. p.ascierto@istitutotumori.na.it., Daniele B; Department of Oncology and Medical Oncology Unit, G. Rummo Hospital, Benevento, Italy., Hammers H; UT Southwestern, Medical Center, Dallas, TX, USA., Hirsh V; McGill Department of Oncology, McGill University, Montreal, Canada., Kim J; Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Licitra L; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Nanda R; Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy.

المصدر: Journal of translational medicine [J Transl Med] 2017 Oct 11; Vol. 15 (1), pp. 205. Date of Electronic Publication: 2017 Oct 11.

نوع المنشور: Congress

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy*, Neoplasms/*immunology , Neoplasms/*therapy, Antineoplastic Agents/therapeutic use ; Humans ; Neoplasm Metastasis ; Neoplasms/drug therapy

المؤلفون: Matossian, Margarite, Chen, Nan, Nanda, Rita^{Aff1, IDs12609023004924_cor3}

المصدر: Current Breast Cancer Reports. 15(3):266-278

المؤلفون: Li, Wen, Le, Nu N, Onishi, Natsuko, Newitt, David C, Wilmes, Lisa J, Gibbs, Jessica E, Carmona-Bozo, Julia, Liang, Jiachao, Partridge, Savannah C, Price, Elissa R, Joe, Bonnie N, Kornak, John, Magbanua, Mark Jesus M, Nanda, Rita, LeStage, Barbara, Esserman, Laura J, Group, I-SPY Imaging Working, Network, I-SPY Investigator, Veer, Laura J van’t, Hylton, Nola M

المصدر: Cancers. 14(18)

مصطلحات موضوعية: Cancer, Breast Cancer, Clinical Research, Biomedical Imaging, diffusion-weighted MRI, breast cancer, immunotherapy, pathologic complete response, neoadjuvant therapy, Oncology and Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/53268104

المؤلفون: Pusztai, Lajos, Yau, Christina, Han, Hyo, Du, Lili, Wallace, Anne, String-Reasor, Erica, Boughey, Judy, Chien, A, Elias, Anthony, Beckwith, Heather, Nanda, Rita, Albain, Kathy, Clark, Amy, Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Helsten, Theresa, Forero-Torres, Andres, Liu, Minetta, Brown-Swigart, Lamorna, Petricoin, Emmanuel, Wulfkuhle, Julia, Asare, Smita, Wilson, Amy, Singhrao, Ruby, Sit, Laura, Berry, Scott, Sanil, Ashish, Asare, Adam, Matthews, Jeffrey, Perlmutter, Jane, Melisko, Michelle, Rugo, Hope, Schwab, Richard, Symmans, W, Yee, Doug, Vant Veer, Laura, DeMichele, Angela, Berry, Donald, Esserman, Laura, Hylton, Nola, Wolf, Denise, Shatsky, Rebecca, Hirst, Gillian

المصدر: Cancer Cell. 39(7)

مصطلحات موضوعية: DNA repair inhibitor, breast cancer, clinical trial, immunotherapy, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Female, Follow-Up Studies, Humans, Middle Aged, Neoadjuvant Therapy, Paclitaxel, Phthalazines, Piperazines, Prognosis, Receptor, ErbB-2, Survival Rate, Young Adult

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/3r25p13v

المؤلفون: Howard, Frederick M.^{Aff1, IDs10549022066656_cor1}, Pearson, Alexander T., Nanda, Rita

المصدر: Breast Cancer Research and Treatment. 195(1):1-15

المؤلفون: Swoboda, April^Aff3, Nanda, Rita^Aff3

المساهمون: Rosen, Steven T., Series editor^Aff1, Gradishar, William J., editor^Aff2

المصدر: Optimizing Breast Cancer Management. 173:155-165

المؤلفون: Swoboda, April T.^Aff2, Nanda, Rita^Aff2

المساهمون: Tan, Antoinette R., editor^Aff1

المصدر: Triple-Negative Breast Cancer : A Clinician’s Guide. :117-140

Degree: MD

المؤلفون: Swoboda, April, Nanda, Rita

المصدر: Current Breast Cancer Reports. :1-9